What Experts Say About Us - AME Publishing Company

The panel of contributing authors was excellent and the quality of the systematic reviews was outstanding.

Sunil Krishnan, MD, FACP
John E. and Dorothy J. Harris Professor,
Director, Center for Radiation Oncology Research,
Professor, Department of Radiation Oncology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas, USA

An emphasis is placed on securing leading experts in the field to provide state-of-the-art articles related to their particular expertise. Furthermore, the journal strongly encourages the inclusion of authors and reviewers from across the globe, giving the journal a wider, more inclusive scope.

Faysal A. Yafi, MD, FRCSC
Clinical Instructor, Department of Urology,
Tulane University School of Medicine,
New Orleans, LA, USA

An emphasis is placed on securing leading experts in the field to provide state-of-the-art articles related to their particular expertise. Furthermore, the journal strongly encourages the inclusion of authors and reviewers from across the globe, giving the journal a wider, more inclusive, scope.

Wayne J.G. Hellstrom, MD, FACS
Professor of Urology,
Tulane University School of Medicine,
New Orleans, LA, USA

I have been translational researcher in the field of particle beam therapy for more than 20 years, and highly value this journal as a multidisciplinary forum for researchers and clinicians active in translational cancer research.

Reinhard W. Schulte, MD, Dr. Med., Dipl. Phys., DABR
Professor, Loma Linda University,
Loma Linda University Medical Center, Loma Linda, USA

There is strong, and in my experience, sometimes zealous peer review. The papers that are published are state of the art, unique and valuable contributions.

Barry Kogan, MD
Chair of Urology, Albany Medical College, Albany, USA

The editorial office of the journal is highly motivated and proactively engaged in establishing the highest quality journal standards.

Pataje G.S. Prasanna, PhD
Program Director, Radiation Research,
Radiation Therapy Development Branch,
Division of Cancer Treatment and Diagnosis,
National Cancer Institute, Bethesda, MD, USA